Table 3.
Investigation results
| Investigation | At presentation | 5 days | 32 days |
|---|---|---|---|
| Full blood count | |||
| PCV | 34% | 39% | |
| ERS | 50 mm/1st h | 12 mm/1st h | |
| Hb | 11.3 g/dl | 13.0 g/dl | |
| WBC | 13,300/dl | 7200/dl | |
| Neutrophils | 73% | 50% | |
| Lymphocytes | 27% | 49% | |
| Monocytes | 0% | 0% | |
| Eosinophils | 0% | 1% | |
| Platelets | 233×109/l | ||
| Prothrombin time | Normal | ||
| Activated partial | Normal | ||
| Thromboplastin time | Normal |
PCV – Packed cell volume; ESR – Erythrocyte sedimentation rate; Hb – Hemoglobin; WBC – White blood cell